Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Kepler Cheuvreux's Digital Autumn Conference 2020
10 slides from Coloplast A/s Class B's conference presentation, 2020
Slide 1: Making it easier to be yourself
Making it easier to be yourself Clothes are a part of my identity, so I worried about what I could wear after my operation. Today, I still dress the way I want. Stina Leading intimate healthcare Kepler Cheuvreux’s Digital Autumn Conference 2020 Anders Lonning-Skovgaard, EVP & CFO Making life easier
Slide 2: Forward-looking statements
Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements
Slide 3: Coloplast has four business areas all with global sales presence
Coloplast has four business areas all with global sales presence Group revenue 2018/19 by segment Group revenue 2018/19 by geography X = Coloplast’s global market position Emerging markets 17% Ostomy Care Continence 40% Care 36% #1 DKK DKK 17.9bn #1 Other 17.9bn European developed markets markets 59
Slide 4: The Chronic Care model secures a predictable revenue stream and stable revenue growth
The Chronic Care model secures a predictable revenue stream and stable revenue growth The chronic care user flow Chronic Care condition New user Installed base of users Stable flow of loyal users Solid reimbursement Coloplast group revenues Revenue (DKKbn) Organic growth (%) 10 10 9 8 8 8 8 7 7 7 7
Slide 5: Coloplast has strong market positions in Europe and great commercial potential outside Europe
Coloplast has strong market positions in Europe and great commercial potential outside Europe Europe Developed Emerging Ostomy Continence Urology Wound Care Addressable market 18-19n 13-14bn 12-13bn 22-24bn 4-5% 5-6% 3-5% 2-4% Size in DKK Growth in %1 Coloplast 40 - 50% 45 - 55% 20 - 25% 5 - 10% reg
Slide 6: Coloplast's LEAD20 strategy was focused on revenue and earnings growth across 4 major themes
Coloplast’s LEAD20 strategy was focused on revenue and earnings growth across 4 major themes 1 Superior products & innovation 2 Unique user focused market approach 3 Unparalleled efficiency 4 Strong leadership development Page 6
Slide 7: Long-term guidance for the LEAD20 strategy period
Long-term guidance for the LEAD20 strategy period aimed at accelerating growth and long-term value creation Revenue growth EBIT margin annual organic constant currencies 7–9% >30% Page 7
Slide 8: Financial guidance for FY 2019/20 – guidance range narrowed
Financial guidance for FY 2019/20 – guidance range narrowed Guidance 2019/20 Guidance 2019/20 (DKK)* Key assumptions • The situation in Interventional Urology gradually normalises in Q4 • Majority of 150m stock building from Q2 reversed in Q3 – expected to ~4% fully reverse in Q4 3-4% Sales growth f
Slide 9: Key highlights from 2018/19 Corporate Responsibility initiatives
Key highlights from 2018/19 Corporate Responsibility initiatives Empowering People Acting respectfully Minimising footprint Our Access to Healthcare programme has New target to increase share of diverse teams Achieved 100% electricity from supported 62 projects since 2007. (gender, generation, natio
Slide 10: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast Group - Ostomy Care /
Coloplast — Kepler Cheuvreux's Digital Autumn Conference 2020 on 6ix